abstract |
A humanized monoclonal antibody for blocking AGR2 blocking monoclonal antibodies, particularly AGR2, is disclosed. Also disclosed are pharmaceutical compositions containing such antibodies, methods of producing such antibodies, and use of said antibodies in blocking tumor growth and metastasis. |